Pharmafile Logo

US manufacturing

- PMLiVE

Gilead and PAHO announce milestone partnership to accelerate access to HIV pre-exposure treatment

The agreement will improve access to twice-yearly Lenacapavir across Latin America and the Caribbean

- PMLiVE

Gilead opens new research centre bringing together oncology, inflammation and research data science teams

The centre in California supports the company’s $32bn US investment

- PMLiVE

Genentech’s US manufacturing facility advances with construction milestone

The facility is part of Roche and Genentech’s broader $50bn commitment to US R&D and manufacturing infrastructure

Fan image of Site Report

New Cuttsy+Cuttsy research shows why site support matters more than ever

Cuttsy+Cuttsy's upcoming report, 'The site factor: Where protocol meets practice in clinical trials', delves into the critical role of site staff in clinical research, offering insights into their daily challenges,...

Cuttsy + Cuttsy

- PMLiVE

Amgen agrees to lower prescription drug costs in deal with US government

The company has invested $40bn in US R&D and manufacturing in the past seven years

- PMLiVE

Lack of education causes patients to stop vital treatments, survey finds

Over three quarters of healthcare professionals call for co-created patient materials to drive engagement and trust, ultimately helping more patients benefit from prescribed treatments. Nearly 80% of healthcare professionals identify...

Healthinote (by Cognitant)

- PMLiVE

Lilly announces plans for $6bn US manufacture facility

The site is the third of four new US sites that Lilly has announced

- PMLiVE

AstraZeneca announces $2bn investment in US manufacturing

The new and expanded facilities will support production of rare disease drug treatments

- PMLiVE

AstraZeneca to invest $4.5bn in US manufacturing facility

The investment will further support the company’s growing oncology pipeline

- PMLiVE

Gilead Sciences’ Biktarvy granted FDA approval for expanded HIV use

An estimated 1.2 million people in the US are currently living with the virus

Patient talking to HCP

Why fresh patient voices are critical to improve clinical trials outcomes

Discover why diverse patient voices, especially first-time participants, are key to improving clinical trials. Boost recruitment, retention, and patient-centric research.

Cuttsy + Cuttsy

- PMLiVE

Gilead Sciences and Kymera enter oncology partnership worth up to $750m

The companies will focus on advancing Kymera’s oral molecular glue degrader programme

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links